| Literature DB >> 32119837 |
Shanyi Li1, Hsiao-Chen Dina Kuo2, Ran Yin1, Renyi Wu1, Xia Liu1, Lujing Wang2, Rasika Hudlikar1, Rebecca Mary Peter2, Ah-Ng Kong3.
Abstract
Triterpenoids are a powerful group of phytochemicals derived from plant foods and herbs. Many reports have shown that they possess chemopreventive and chemotherapeutic effects not only in cell lines and animal models but also in clinical trials. Because epigenetic changes could potentially occur in the early stages of <span class="Disease">carcinogenesis preceding genetic mutations, epigenetics are considered promising targets in early interventions against cancer using epigenetic bioactive substances. The biological properties of triterpenoids in cancer prevention and in health have multiple mechanisms, including antioxidant and anti-inflammatory activities, cell cycle regulation, as well as epigenetic/epigenomic regulation. In this review, we will discuss and summarize the latest advances in the study of the pharmacological effects of triterpenoids in cancer chemoprevention and in health, including the epigenetic machinery.Entities:
Keywords: Cancer; Chemoprevention; Epigenetics; Phytochemicals; Triterpenoids
Mesh:
Substances:
Year: 2020 PMID: 32119837 PMCID: PMC7174132 DOI: 10.1016/j.bcp.2020.113890
Source DB: PubMed Journal: Biochem Pharmacol ISSN: 0006-2952 Impact factor: 5.858